GSK Early Career Endometrial Cancer Research Grant supports fellows and early-career faculty pursuing innovative endometrial cancer research to build preliminary data and advance toward research independence.
Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal) | February 9, 2027 (Award notification) | March 19–22, 2027 (Award presentation)
Funding Amounts: $75,000 for one year
Summary: Supports fellows and early-career faculty conducting innovative endometrial cancer research as they transition toward research independence.
Key Information: Research must take place at a U.S. institution; non-SGO members need an SGO-member co-investigator or sponsor.
The Foundation for Women’s Cancer (FWC) offers this grant through its 2026–2027 Research Grants program under Endometrial/Uterine Cancer Grants. The award supports promising fellows and early-career faculty pursuing innovative endometrial cancer research, providing support during the transition to an independent research career.
Projects may encompass basic, translational, clinical, or population-based research relevant to prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Priority goes to innovative work that can generate preliminary data and catalyze future research and extramural funding. Applicants should demonstrate a strong commitment to gynecologic oncology research and explain how the proposed work will advance their development as independent investigators.